Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jun 2026 for Evolent Health, Inc.. Read the official filing
Filing timeline
BuySaleBrendan B. Springstubb
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
0%
Median T+90
-17.2%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -24.7%Entry US$3.69 · Close at T+90 US$2.78
- -67.8%Entry US$9.39 · Close at T+365 US$3.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brendan B. Springstubb: trading record in brief
Brendan B. Springstubb appears in our data through filings on Evolent Health, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 3 March 2025 and the latest from 4 June 2026.
Every open-market trade on record is a purchase: 2 purchases worth €162k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants.
The latest filing, published on 8 June 2026, reports a share grant in Evolent Health, Inc. The most recent open-market purchase was published on 19 November 2025, 333 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brendan B. Springstubb
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
41,096 shares0Class A Common StockSEC:0001628908-26-000041:0
10,000 shares@ US$3.819920.4% of flowClass A Common StockSEC:0001628908-25-000138:0
Canonical exit: 16 Feb 2026 (T+90)
21,979 shares0Class A Common StockSEC:0001628908-25-000086:0
15,000 shares@ US$9.2779.6% of flowClass A Common StockSEC:0001628908-25-000042:0
Canonical exit: 5 Jun 2025 (T+90)
6,842 shares0Class A Common StockSEC:0001628908-25-000034:0
5 of 5 declarations
